BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2183724)

  • 1. Reduction in ESRD reimbursement rate: identifying research priorities and quality indicators.
    Parker J
    ANNA J; 1990 Apr; 17(2):147-54. PubMed ID: 2183724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The direction of end-stage renal disease reimbursement in the United States.
    Lockridge RS
    Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicare program; end-stage renal disease prospective payment system. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2010 Aug; 75(155):49029-214. PubMed ID: 20712086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare program; end-stage renal disease prospective payment system, quality incentive program, and bad debt reductions for all Medicare providers. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2012 Nov; 77(218):67450-531. PubMed ID: 23139948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surviving change: Can the ESRD provisions in the SCHIP create a level playing field?
    Gardner AV
    Nephrol News Issues; 2007 Sep; 21(10):52-3. PubMed ID: 17918480
    [No Abstract]   [Full Text] [Related]  

  • 6. Linking reimbursement and quality.
    Neumann ME
    Nephrol News Issues; 2004 Oct; 18(11):21-4. PubMed ID: 15551611
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythropoietin & ESRD payments: a promising policy outcome?
    Roe W
    Nephrol News Issues; 1989 Sep; 3(9):34-5. PubMed ID: 2682270
    [No Abstract]   [Full Text] [Related]  

  • 8. Medicare program: End-Stage Renal Disease program; revised network area designations--HCFA. Final rule.
    Fed Regist; 1987 Oct; 52(191):37018-25. PubMed ID: 10301901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health insurance exchanges and ESRD.
    Schrag WF
    Nephrol News Issues; 2014 Jan; 28(1):18. PubMed ID: 24600925
    [No Abstract]   [Full Text] [Related]  

  • 10. Health Policy and Kidney Care in the United States: Core Curriculum 2020.
    Mendu ML; Weiner DE
    Am J Kidney Dis; 2020 Nov; 76(5):720-730. PubMed ID: 32771281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red blood cell (RBC) transfusion rates among US chronic dialysis patients during changes to Medicare end-stage renal disease (ESRD) reimbursement systems and erythropoiesis stimulating agent (ESA) labels.
    Cappell KA; Shreay S; Cao Z; Varker HV; Paoli CJ; Gitlin M
    BMC Nephrol; 2014 Jul; 15():116. PubMed ID: 25015348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of reimbursement regulations on patient management.
    Hull AR
    Am J Kidney Dis; 1992 Jul; 20(1 Suppl 1):8-11. PubMed ID: 1626555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Futuristic plans for ESRD--a new bundled payment system.
    Michael M
    Nephrol News Issues; 2005 Sep; 19(10):52, 54. PubMed ID: 16187649
    [No Abstract]   [Full Text] [Related]  

  • 14. Epidemiology of end stage renal disease and implications for public policy.
    Rubin RJ
    Public Health Rep; 1984; 99(5):492-8. PubMed ID: 6435162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bundled payment for ESRD--including ESAs in Medicare's dialysis package.
    Iglehart JK
    N Engl J Med; 2011 Feb; 364(7):593-5. PubMed ID: 21323538
    [No Abstract]   [Full Text] [Related]  

  • 16. The publication of the proposed new regulations for the ESRD program: an historic event for nephrology nursing.
    Dinwiddie LC
    Nephrol Nurs J; 2005; 32(1):11-2. PubMed ID: 15787080
    [No Abstract]   [Full Text] [Related]  

  • 17. GAO looks at bundling outside ESRD.
    Neumann ME
    Nephrol News Issues; 2011 Apr; 25(4):8. PubMed ID: 21542505
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicare program; End Stage Renal Disease Program; responsibilities of network organizations--HCFA. Final rule.
    Fed Regist; 1988 Jan; 53(13):1617-20. PubMed ID: 10302132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health policy, disparities, and the kidney.
    Williams AW
    Adv Chronic Kidney Dis; 2015 Jan; 22(1):54-9. PubMed ID: 25573513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicare Program; End-Stage Renal Disease Prospective Payment System, and Quality Incentive Program. Final Rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2015 Nov; 80(215):68967-9077. PubMed ID: 26552112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.